Go Pro

Insider Selling: Plexus (NASDAQ:PLXS) Director Sells 500 Shares

Plexus logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Plexus Director Karen Marie Rapp sold 500 shares at an average price of $240.87, generating $120,435. The transaction, conducted under a Rule 10b5-1 trading plan, reduced her direct holdings by 6.22% to 7,535 shares.
  • Plexus shares opened at $239.47, down 0.6%, while the company reported quarterly earnings of $2.32 per share and revenue of $1.30 billion—both above analyst expectations. Revenue increased 28.2% year over year.
  • Analysts remain broadly positive, with the stock carrying a consensus “Buy” rating and an average price target of $273. Institutional investors own approximately 94.45% of Plexus shares.
  • Interested in Plexus? Here are five stocks we like better.

Plexus Corp. (NASDAQ:PLXS - Get Free Report) Director Karen Marie Rapp sold 500 shares of the company's stock in a transaction on Monday, August 31st. The shares were sold at an average price of $240.87, for a total transaction of $120,435.00. Following the sale, the director directly owned 7,535 shares in the company, valued at $1,814,955.45. This trade represents a 6.22% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Plexus Stock Down 0.6%

Shares of NASDAQ:PLXS opened at $239.47 on Tuesday. The company has a market capitalization of $6.41 billion, a price-to-earnings ratio of 35.32 and a beta of 0.90. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.49 and a quick ratio of 0.72. The business's 50-day moving average is $262.34 and its 200-day moving average is $244.46. Plexus Corp. has a 1 year low of $132.03 and a 1 year high of $307.06.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, topping analysts' consensus estimates of $2.13 by $0.19. Plexus had a return on equity of 12.46% and a net margin of 4.03%.The business had revenue of $1.30 billion during the quarter, compared to the consensus estimate of $1.23 billion. During the same period in the previous year, the company posted $1.64 earnings per share. The firm's revenue for the quarter was up 28.2% on a year-over-year basis. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Equities research analysts predict that Plexus Corp. will post 7.11 earnings per share for the current year.

Institutional Investors Weigh In On Plexus

Large investors have recently added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Plexus during the 2nd quarter valued at about $32,000. Covestor Ltd boosted its position in shares of Plexus by 207.7% in the fourth quarter. Covestor Ltd now owns 240 shares of the technology company's stock valued at $35,000 after acquiring an additional 162 shares during the period. Kilter Group LLC purchased a new position in Plexus during the second quarter valued at approximately $40,000. Allworth Financial LP increased its holdings in Plexus by 20.8% during the 4th quarter. Allworth Financial LP now owns 302 shares of the technology company's stock worth $44,000 after acquiring an additional 52 shares during the period. Finally, Persistent Asset Partners Ltd purchased a new stake in Plexus in the 2nd quarter worth approximately $71,000. Hedge funds and other institutional investors own 94.45% of the company's stock.

Wall Street Analyst Weigh In

PLXS has been the subject of several analyst reports. Needham & Company LLC reiterated a "buy" rating and issued a $310.00 target price on shares of Plexus in a report on Friday, August 14th. Sidoti upgraded shares of Plexus from a "neutral" rating to a "buy" rating and set a $308.00 price target on the stock in a report on Friday, July 31st. Zacks Research raised shares of Plexus from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 11th. Stifel Nicolaus increased their price objective on shares of Plexus from $280.00 to $330.00 and gave the company a "buy" rating in a research note on Monday, June 22nd. Finally, Weiss Ratings cut shares of Plexus from a "buy (b)" rating to a "buy (b-)" rating in a research report on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company. According to data from MarketBeat.com, Plexus currently has an average rating of "Buy" and a consensus target price of $273.00.

Get Our Latest Report on PLXS

About Plexus

(Get Free Report)

Plexus Corp. NASDAQ: PLXS is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Featured Stories

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines